切换至 "中华医学电子期刊资源库"

中华肾病研究电子杂志 ›› 2015, Vol. 04 ›› Issue (06) : 294 -297. doi: 10.3877/cma.j.issn.2095-3216.2015.06.005

所属专题: 文献

专家论坛

肿瘤及重金属相关膜性肾病的诊断与治疗
魏日胞1()   
  1. 1. 100853 解放军总医院肾脏病科、解放军肾脏病研究所、肾脏疾病国家重点实验室、国家慢性肾病临床医学研究中心
  • 出版日期:2015-12-28
  • 通信作者: 魏日胞
  • 基金资助:
    国家自然科学基金(81273968, 81471027); 民政部老龄委专项课题(QLB2014W002); 解放军总医院百项优势项目(YS201408)

Diagnosis and treatment for tumor- and heavy metals-related membranous nephropathy

Ribao Wei1,()   

  1. 1. Department of Nephrology, Chinese PLA General Hospital, Chinese PLA Institute of Nephology, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing 100853, China
  • Published:2015-12-28
  • Corresponding author: Ribao Wei
  • About author:
    Corresponding author: Wei Ribao, Email:
引用本文:

魏日胞. 肿瘤及重金属相关膜性肾病的诊断与治疗[J/OL]. 中华肾病研究电子杂志, 2015, 04(06): 294-297.

Ribao Wei. Diagnosis and treatment for tumor- and heavy metals-related membranous nephropathy[J/OL]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2015, 04(06): 294-297.

膜性肾病是引起成人肾病综合征最常见的病因之一,按其病因可分为原发性和继发性,其中继发性膜性肾病约占总体膜性肾病的1/3。肿瘤及药物相关膜性肾病又是继发性膜性肾病中有意义、也有一定争议的病因,临床需要关注并加强甄别。虽然目前尚不能够准确区分肿瘤相关性膜性肾病与肿瘤合并特发性膜性肾病,但临床应注意:对于中老年膜性肾病患者,要警惕肿瘤的存在,注意肿瘤的筛检;对于发现肿瘤的患者,应注意监测肾损害指标,及时发现肾脏损害并给予干预治疗;对于中老年膜性肾病肾病综合征患者,在应用激素免疫抑制剂治疗前及治疗过程中,也要注意排除肿瘤的可能性。对于有汞接触史的膜性肾病患者,要注意排除汞中毒相关膜性肾病。

Membranous nephropathy (MN) is one of the most common causes of nephrotic syndrome (NS) in adults, which can be divided into the primary and secondary types. The secondary MN accounts for about 1/3 of the total MN. Among the secondary MN, the tumors- and drugs-related MN is of significance and controversial, which need to be paid attention to and screened clinically. Although it is hard to differentiate accurately between tumors-related MN and IMN complicated with tumors, the following should be noted: the existence of tumors should not be ignored in middle-elderly patients with MN, which should be screened carefully; if the tumor is found, indexes of early renal damage should be measured for proper diagnosis and necessary interfering treatment; and for nephrotic syndrome in the middle-elderly patients with MN, before and during the application of corticosteroids and immunosuppressants, the possibility of tumors should also be ruled out. For MN patients who have a history of exposure to mercury, attention should be paid to exclude the mercury poisoning-related MN.

1
Burstein DM, Korbet SM, Schwartz MM. Membranous glomerulonephritis and malignancy [J]. Am J Kidney Dis, 1993, 22(1): 5-10.
2
刘芳,付平. 恶性肿瘤肾损害[J]. 中国实用内科杂志,2011, 31(2): 100-102.
3
Jefferson JA, Couser WG. Therapy of membranous nephropathy associated with malignancy and secondary causes [J]. Semin Nephrol, 2003, 23(4): 400-405.
4
田茂露,胡章学. 肿瘤相关性膜性肾病[J]. 中国中西医结合肾病杂志,2012,13(5): 451-453.
5
Ohtani H, Wakui H, Komatsuda A, et al. Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy [J]. Nephrol Dial Transplant, 2004, 19(3): 574-579.
6
Qu Z, Liu G, Li J, et al. Absence of glomerular IgG4 deposition in patients with membranous nephropathy may indicate malignancy [J]. Nephrol Dial Transplant, 2012, 27(5): 1931-1937.
7
Beck LH, Bonegio RG, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy [J]. N Engl J Med, 2009, 361(1): 11-21.
8
Qin W, Beck LH, Zeng C, et al. Anti-phospholipase A2 receptor antibody in membranous nephropathy [J]. J Am Soc Nephrol, 2011, 22(6): 1137-1143.
9
张义德,李世军,刘志红. 恶性肿瘤相关性膜性肾病[J]. 肾脏病与透析肾移植杂志,2008,17(3): 295-300.
10
周薇,张俊霞,徐金升,等. 恶性肿瘤相关性肾病综合征12例临床及病理分析[J]. 疑难病杂志,2013,12(2): 142-143.
11
魏日胞,王远大,荣娜,等. 膜性肾病合并食管癌及多发深静脉血栓一例[J/CD]. 中华肾病研究电子杂志,2013,2(1): 48-50.
12
李嵘,王永星.药物性肾损害[J].世界最新医学信息文摘,2015,15(25): 98.
13
张苏华,刘志红,陈惠萍,等.汞中毒相关性膜性肾病[J].肾脏病与透析肾移植杂志,2008,17(4): 318-324.
14
罗婷,魏日胞,贾楠,等.汞中毒相关膜性肾病的临床治疗并文献复习[J].中国药物应用与监测,2013,10(6): 355-358.
[1] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[2] 李国新, 陈新华. 全腹腔镜下全胃切除术食管空肠吻合的临床研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 1-4.
[3] 陈方鹏, 杨大伟, 金从稳. 腹腔镜近端胃癌切除术联合改良食管胃吻合术重建His角对术后反流性食管炎的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 15-18.
[4] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[5] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[6] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[7] 任佳, 马胜辉, 王馨, 石秀霞, 蔡淑云. 腹腔镜全胃切除、间置空肠代胃术的临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 31-34.
[8] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[9] 吴晖, 佴永军, 施雪松, 魏晓为. 两种解剖入路下行直肠癌侧方淋巴结清扫的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 40-43.
[10] 周世振, 朱兴亚, 袁庆港, 刘理想, 王凯, 缪骥, 丁超, 汪灏, 管文贤. 吲哚菁绿荧光成像技术在腹腔镜直肠癌侧方淋巴结清扫中的应用效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 44-47.
[11] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[12] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[13] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[14] 王露, 周丽君. 全腹腔镜下远端胃大部切除不同吻合方式对胃癌患者胃功能恢复、并发症发生率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 92-95.
[15] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?